Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Takeda Pharma (TKPYY)

Takeda Pharma (TKPYY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 25,919,552
  • Shares Outstanding, K 1,562,360
  • Annual Sales, $ 15,935 M
  • Annual Income, $ 1,682 M
  • 60-Month Beta 0.42
  • Price/Sales 1.64
  • Price/Cash Flow N/A
  • Price/Book 1.36
  • Price/Earnings ttm 12.22
  • Earnings Per Share ttm 1.37
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/07/19
  • Annual Dividend & Yield 0.58 (3.48%)
  • Most Recent Dividend 0.288 on 09/27/18
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.5000 +7.03%
on 12/18/18
19.2300 -13.73%
on 11/26/18
-2.6300 (-13.68%)
since 11/21/18
3-Month
15.5000 +7.03%
on 12/18/18
21.9399 -24.38%
on 09/26/18
-4.3650 (-20.83%)
since 09/21/18
52-Week
15.5000 +7.03%
on 12/18/18
31.2900 -46.98%
on 02/01/18
-11.8100 (-41.58%)
since 12/21/17

Most Recent Stories

More News
Psoriasis Drug Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2025

In its latest report on provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status...

AMGN : 239.71 (-0.31%)
BIIB : 289.45 (+0.32%)
CELGZ : 0.47 (+2.15%)
LLY : 150.09 (-0.25%)
GSK : 40.55 (-1.55%)
MRK : 83.48 (-0.07%)
NVS : 84.65 (-0.84%)
PFE : 38.06 (-0.29%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
BioLife Plasma Services Announces Opening of First Plasma Collection Center in Louisiana

BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of a new plasma collection center in Baton Rouge to collect standard...

TKPYY : 16.5900 (-0.90%)
Takeda to Present Rare Bleeding Disorders Research Highlighting Need for Real-World Evidence at NHF Bleeding Disorders Conference 2020

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) ("Takeda"), today presented three abstracts at the 72nd National Hemophilia Foundation's Bleeding Disorders Conference, underscoring the need...

TKPYY : 16.5900 (-0.90%)
Takeda Announces FY2020 Q1 Results; Confirms Management Guidance & Raises Reported Operating Profit And Reported Net Profit for the Full Year

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) ("Takeda") today announced financial results for the first quarter of fiscal year 2020 (quarter ended June 30, 2020). Based on the first quarter...

TKPYY : 16.5900 (-0.90%)
Plasma Therapy Global Market Report 2020-30: Covid 19 Growth and Change

, /PRNewswire/ -- Major players in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex, Inc., Biotest AG, China Biologic Products Holdings, Inc.,...

CSLLY : 99.8100 (+0.43%)
TKPYY : 16.5900 (-0.90%)
Takeda Announces U.S. FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

--- Pevonedistat Could be First Novel Treatment Option for HR-MDS in More Than a Decade -

TKPYY : 16.5900 (-0.90%)
Convalescent Plasma Therapy Global Market Report 2020-30: Covid 19 Implications and Growth

Reportlinker.com announces the release of the report "Convalescent Plasma Therapy Global Market Report 2020-30: Covid 19 Implications and Growth" - https://www.reportlinker.com/p05932636/?utm_source=GNW...

TKPYY : 16.5900 (-0.90%)
Translate Bio Announces Pricing of Public Offering of Common Stock

Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene...

TKPYY : 16.5900 (-0.90%)
TBIO : 14.59 (+1.32%)
Research Uncovers New Role Psychedelics Could Play in Therapy

, /PRNewswire/ -- The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases and it operates in one of the most diverse and complex markets. The pharmaceutical market is also...

TKPYY : 16.5900 (-0.90%)
MYCOF : 0.3955 (+3.86%)
MYCO.CN : 0.530 (+1.92%)
TAK : 18.49 (-0.32%)
TEVA : 11.50 (-0.61%)
MRNS : 1.7900 (-1.10%)
SUPN : 24.15 (+3.43%)
Translate Bio Announces Proposed Public Offering of Common Stock

Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene...

TKPYY : 16.5900 (-0.90%)
TBIO : 14.59 (+1.32%)
Trade TKPYY with:

Key Turning Points

2nd Resistance Point 17.1900
1st Resistance Point 16.8900
Last Price 16.5900
1st Support Level 16.3200
2nd Support Level 16.0500

See More

52-Week High 31.2900
Fibonacci 61.8% 25.2582
Fibonacci 50% 23.3950
Fibonacci 38.2% 21.5318
Last Price 16.5900
52-Week Low 15.5000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar